As an expert in radioisotopes,
we will contribute to the development of
human health and medical care
News
-
-
2026.06.23InformationDr. Masato Murakami, President and Representative Director of the Company, Appointed President of the Japan Radiopharmaceuticals Association
-
2026.06.11Press ReleasePeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
-
2026.06.11Press ReleaseNCC and PeptiDream Announce First Dosing of 64Cu-PD-29875 in Patients with Gastric Cancer（PeptiDream Inc.）
-
2026.04.20InformationPDRadiopharma to Present at the Drug Discovery Symposium (Protein/Peptide Track) at CPHI Japan 2026
-
2026.04.17InformationDr. Masato Murakami, President and Representative Director, Participates in a Japan Atomic Energy Commission Expert Subcommittee
-